Source: Eur Respir J, 53 (5) 1900556; 10.1183/13993003.00556-2019
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Emily M. Beck, Nathan D. Hatton, John J. Ryan. Novel techniques for advancing our understanding of pulmonary arterial hypertension. Eur Respir J, 53 (5) 1900556; 10.1183/13993003.00556-2019

Member's Comments

No comment yet.

Related content which might interest you: Novel therapeutic perspectives in pulmonary arterial hypertension Source: Eur Respir J 2003; 22: 193-194 Year: 2003 Novel insights into the pathogenesis of pulmonary arterial hypertension Source: Virtual Congress 2020 – Pulmonary vascular diseases Year: 2020 The genetics of pulmonary arterial hypertension Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling Year: 2005 The revolution of pulmonary arterial hypertension Source: Eur Respir Rev 2016; 25: 361-363 Year: 2016 Novel biomarkers in idiopathic pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Towards a molecular classification of pulmonary arterial hypertension Source: Eur Respir J 2016; 48: 987-989 Year: 2016 Targeted proteomics of right heart adaptation to pulmonary arterial hypertension Source: Eur Respir J, 57 (4) 2002428; 10.1183/13993003.02428-2020 Year: 2021 The future of treatment for pulmonary arterial hypertension Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease Year: 2018 The future of treatment for pulmonary arterial hypertension Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease Year: 2012 The future of treatment for pulmonary arterial hypertension Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2014 The future of treatment for pulmonary arterial hypertension Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2017 The challenges in paediatric pulmonary arterial hypertension Source: Eur Respir Rev 2014; 23: 498-504 Year: 2014 Identification of treatment goals in paediatric pulmonary arterial hypertension Source: Eur Respir J 2014; 44: 1616-1626 Year: 2014 Volatolomics of breath as an emerging frontier in pulmonary arterial hypertension Source: Eur Respir J , 49 (2) 1601897; DOI: 10.1183/13993003.01897-2016 Year: 2017 Modern age pathology of pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012 A paradigm shift in pulmonary arterial hypertension management Source: Eur Respir Rev 2013; 22: 423-426 Year: 2013 Multi-omic profiling in pulmonary arterial hypertension Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension Year: 2020 Partitioning of pulmonary vascular resistances in group 2 pulmonary hypertension: insightful suggestions for bridging haemodynamics to underlying mechanisms Source: Eur Respir J, 51 (5) 1800816; 10.1183/13993003.00816-2018 Year: 2018 Applying pharmacogenomics to pulmonary arterial hypertension (PAH): A target-based approach to therapy Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012